Munich Re's troubled Ergo explores digital push in China
FRANKFURT, April 28 Ergo, Munich Re's troubled primary insurance company, is making a digital push in the massive Chinese market.
Dec 29 Gevo Inc
* Gevo announces 1-for-20 reverse stock split
* 1-For-20 reverse stock split will be effective as of close of business on January 5, 2017 Source text for Eikon: Further company coverage:
April 28 The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.